BUSINESS COMBINATIONS (Tables)
|
12 Months Ended |
Dec. 31, 2022 |
| Business Combination and Asset Acquisition [Abstract] |
|
| Schedule of Recognized Identified Assets Acquired and Liabilities Assumed |
The following table summarizes the total consideration paid for Pega Medical and the preliminary allocation of purchase price to the estimated fair value of the assets acquired and liabilities assumed at the acquisition date:
| | | | | | | | | | Fair value of estimated total acquisition consideration | | $ | 32,045 | | | Assets | | | | Cash | | 312 | | | Accounts receivable-trade | | 2,100 | | | Inventories | | 4,875 | | | Prepaid expenses and other current assets | | 366 | | | Property and equipment | | 582 | | | Amortizable intangible assets | | 10,370 | | | Other intangible assets | | 3,040 | | | Total assets | | 21,645 | | | Liabilities | | | | Accounts payable-trade | | 1,682 | | | Other current liabilities | | 1,141 | | | Deferred tax liability | | 3,305 | | | Total liabilities | | 6,128 | | | Less: total net assets | | 15,517 | | | Goodwill | | $ | 16,528 | |
The following table summarizes the total consideration paid for MD Ortho and the preliminary allocation of purchase price to the estimated fair value of the assets acquired and liabilities assumed at the acquisition date:
| | | | | | | | | | Fair value of estimated total acquisition consideration | | $ | 18,487 | | | Assets | | | | Cash | | 420 | | | Accounts receivable-trade | | 1,062 | | | Inventories | | 1,126 | | | Prepaid expenses and other current assets | | 100 | | | Property and equipment | | 2,444 | | | Amortizable intangible assets | | 9,120 | | | Other intangible assets | | 2,410 | | | Total assets | | 16,682 | | | Liabilities | | | | Accounts payable and accrued liabilities | | 45 | | | Other current liabilities | | 586 | | | Deferred tax liability | | 3,014 | | | Total liabilities | | 3,645 | | | Less: total net assets | | 13,037 | | | Goodwill | | $ | 5,450 | |
The following table summarizes the total consideration paid for ApiFix and allocation of purchase price to the final fair value of the assets acquired and liabilities assumed at the acquisition date (in thousands): | | | | | | | | | | Description | | Amount | | Fair value of total acquisition consideration | | $ | 87,379 | | | Assets | | | | Cash | | 344 | | | Accounts receivable-trade | | 245 | | | Inventories | | 685 | | | Prepaid expenses and other current assets | | 77 | | | Property and equipment | | 153 | | | Amortizable intangible assets | | 32,150 | | | Other intangible assets | | 8,640 | | | Operating lease right-of-use asset | | 104 | | | Total assets | | 42,398 | | | Liabilities | | | | Accounts payable and accrued liabilities | | 226 | | | Operating lease liabilities | | 106 | | | Other current liabilities | | 270 | | | Deferred income taxes | | 6,487 | | | | | | Total liabilities | | 7,089 | | | Less: total net assets | | 35,309 | | | Goodwill | | $ | 52,070 | | The following table summarizes the total consideration paid for Telos and allocation of purchase price to the final fair value of the assets acquired and liabilities assumed at the acquisition date (in thousands): | | | | | | | | | | Description | | Amount | | Fair value of total acquisition consideration | | $ | 3,318 | | | Assets | | | | Cash | | 81 | | | Accounts receivable-trade | | 215 | | | | | | Prepaid expenses and other current assets | | 38 | | | Property and equipment | | 10 | | | Amortizable intangible assets | | 950 | | | Other intangible assets | | $ | 210 | | | Total assets | | 1,504 | | | Liabilities | | | | Accounts payable and accrued liabilities | | 60 | | | | | | | | | | | | Total liabilities | | 60 | | | Less: total net assets | | 1,444 | | | Goodwill | | $ | 1,874 | |
|
| Schedule of Indefinite-lived Intangible Assets Acquired as Part of Business Combination |
The fair value of identifiable intangible assets was based on preliminary valuations using a combination of the income and cost approach, inputs which would be considered Level 3 under the fair value hierarchy. The estimated fair value and useful life of identifiable intangible assets are as follows:
| | | | | | | | | | | | | | | | | Amount | | Remaining Economic Useful Life | | Trademarks / Names | | $ | 3,040 | | | Indefinite | | Patents | | 3,141 | | | 10 years | | | | | | | Customer Relationships & Other | | 7,229 | | | 15 years | | | $ | 13,410 | | | |
The fair value of identifiable intangible assets was based on preliminary valuations using a combination of the income and cost approach, inputs which would be considered Level 3 under the fair value hierarchy. The estimated fair value and useful life of identifiable intangible assets are as follows:
| | | | | | | | | | | | | | | | | Amount | | Remaining Economic Useful Life | | Trademarks / Names | | $ | 2,410 | | | Indefinite | | Patents | | 2,660 | | | 10 years | | Customer Relationships | | 6,460 | | | 15 years | | | $ | 11,530 | | | |
The fair value of identifiable intangible assets were based on valuations using a combination of the income and cost approach, inputs which would be considered Level 3 under the fair value hierarchy. The estimated fair value and useful life of identifiable intangible assets are as follows: | | | | | | | | | | | | | | | | | Amount | | Remaining Economic Useful Life | | Trademarks / Names | | $ | 8,640 | | | Indefinite | | Patents | | 31,720 | | | 15 years | | Customer Relationships | | 230 | | | 10 years | | Non-competition Agreements | | 200 | | | 4 years | | | $ | 40,790 | | | | The fair value of identifiable intangible assets were based on valuations using a combination of the income and cost approach, inputs which would be considered Level 3 under the fair value hierarchy. The estimated fair value and useful life of identifiable intangible assets are as follows: | | | | | | | | | | | | | | | | | Amount | | Remaining Economic Useful Life | | Trademarks / Names | | $ | 210 | | | Indefinite | | Customer Relationships | | 910 | | | 10 years | | Non-competition Agreements | | 40 | | | 5 years | | | $ | 1,160 | | | |
|
| Schedule of Business Acquisition, Pro Forma Information |
The following table represents the pro forma net revenue and net loss assuming the acquisitions of MD Ortho and Pega Medical occurred on January 1, 2021. | | | | | | | | | | | | | | | | | December 31, | | | 2022 | | 2021 | | Net revenue | | $ | 128,648 | | | $ | 113,899 | | | Net income (loss) | | $ | 2,110 | | | $ | (12,810) | |
|
| Schedule of Total Consideration Transferred After Discounting Future Payments |
The following table reconciles the total consideration transferred after discounting the future payments: | | | | | | | | | | | | | | | | | Consideration | | Present Value | | Cash consideration | | $ | 2,000 | | | $ | 2,000 | | | Payment of ApiFix transaction related costs | | 67 | | | 67 | | | Issuance of common stock | | 35,176 | | | 35,176 | | | Anniversary payments | | 30,000 | | | 22,620 | | | System sales payment | | 41,741 | | | 27,190 | | | Total consideration transferred | | $ | 108,984 | | | $ | 87,053 | |
|
| Schedule of Business Acquisitions by Acquisition, Contingent Consideration |
Presented below is a summary of the present value of the anniversary payments and fair value of the system sales payment related to the ApiFix acquisition: | | | | | | | | | | | | | | | | | | | | | | | December 31, 2022 | | December 31, 2021 | | December 31, 2020 | | Anniversary Payments: | | | | | | | | Second Year Payment | | $ | — | | | $ | 12,862 | | | $ | 12,233 | | | Third Year Payment | | 7,815 | | | 7,075 | | | 6,335 | | | Fourth Year Payment | | 8,019 | | | 7,234 | | | 6,449 | | | Total acquisition installment payable | | 15,834 | | | 27,171 | | | 25,017 | | | Less: current portion of acquisition installment payable | | 7,815 | | | 12,862 | | | 12,233 | | | Acquisition installment payable, net of current portion | | 8,019 | | | 14,309 | | | 12,784 | | | System sales payment | | 2,980 | | | 28,910 | | | 30,710 | | | ApiFix future consideration, net of current portion | | $ | 10,999 | | | $ | 43,219 | | | $ | 43,494 | |
|